{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:15:31Z","timestamp":1789985731620,"version":"4.0.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1-2","license":[{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,8,1]],"date-time":"2002-08-01T00:00:00Z","timestamp":1028160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2002,8]]},"DOI":"10.1023\/a:1016555821581","type":"journal-article","created":{"date-parts":[[2002,12,29]],"date-time":"2002-12-29T03:32:49Z","timestamp":1041132769000},"page":"137-153","source":"Crossref","is-referenced-by-count":18,"title":["Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors"],"prefix":"10.1007","volume":"237","author":[{"given":"Lai","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longwen","family":"Den","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaili","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kylene","family":"Kehn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Maddukuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanese","family":"Baylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Agbottah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylviane","family":"Trigon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Morange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"Mahieux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatah","family":"Kashanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5087780_CR1","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1097\/00042560-199600001-00014","volume":"13","author":"C Beraud","year":"1996","unstructured":"Beraud C, Greene WC: Interaction of HTLV-1 Tax with the human proteasome: Implications for NF-kappa B induction. J Acquir Immune Defic Syndr Hum Retrovirol 13: S76\u2013S84, 1996","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"5087780_CR2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/MMBR.63.2.308-333.1999","volume":"63","author":"P Hollsberg","year":"1999","unstructured":"Hollsberg P: Mechanisms of T-cell activation by human T-cell lymphotropic virus type I. Microbiol Mol Biol Rev 63: 308\u2013333, 1999","journal-title":"Microbiol Mol Biol Rev"},{"key":"5087780_CR3","first-page":"233","volume":"7","author":"XH Li","year":"1999","unstructured":"Li XH, Gaynor RB: Regulation of NF-kappaB by the HTLV-1 Tax protein. Gene Exp 7: 233\u2013245, 1999","journal-title":"Gene Exp"},{"key":"5087780_CR4","doi-asserted-by":"crossref","first-page":"4269","DOI":"10.1002\/j.1460-2075.1993.tb06111.x","volume":"12","author":"C Caron","year":"1993","unstructured":"Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, Jalinot P: Functional and biochemical interaction of the HTLV-1 Tax1 transactivator with TBP. EMBO J 12: 4269\u20134278, 1993","journal-title":"EMBO J"},{"key":"5087780_CR5","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1128\/MCB.16.9.4656","volume":"16","author":"KE Clemens","year":"1996","unstructured":"Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, DeJong J, Roeder R, Brady JN: Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA. Mol Cell Biol 16: 4656\u20134664, 1996","journal-title":"Mol Cell Biol"},{"key":"5087780_CR6","doi-asserted-by":"crossref","first-page":"9396","DOI":"10.1128\/JVI.72.11.9396-9399.1998","volume":"72","author":"MA Colgin","year":"1998","unstructured":"Colgin MA, Nyborg JK: The human T-cell leukemia virus type 1 oncoprotein Tax inhibits the transcriptional activity of c-Myb through competition for the CREB binding protein. J Virol 72: 9396\u20139399, 1998","journal-title":"J Virol"},{"key":"5087780_CR7","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1128\/MCB.20.10.3470-3481.2000","volume":"20","author":"F Gachon","year":"2000","unstructured":"Gachon F, Thebault S, Peleraux A, Devaux C, Mesnard JM: Molecular interactions involved in the transactivation of the human T-cell leukemia virus type 1 promoter mediated by Tax and CREB-2 (ATF-4). Mol Cell Biol 20: 3470\u20133481, 2000","journal-title":"Mol Cell Biol"},{"key":"5087780_CR8","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1128\/MCB.18.9.5052","volume":"18","author":"R Harrod","year":"1998","unstructured":"Harrod R, Tang Y, Nicot C, Lu HS, Vassilev A, Nakatani Y, Giam CZ: An exposed KID-like domain in human T-cell lymphotropic virus type 1 Tax is responsible for the recruitment of coactivators CBP\/p300. Mol Cell Biol 18: 5052\u20135061, 1998","journal-title":"Mol Cell Biol"},{"key":"5087780_CR9","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1038\/sj.onc.1203536","volume":"19","author":"C Nicot","year":"2000","unstructured":"Nicot C, Mahieux R, Opavsky R, Cereseto A, Wolff L, Brady JN, Franchini G: HTLV-1 Tax transrepresses the human c-Myb promoter independently of its interaction with CBP or p300. Oncogene 19: 2155\u20132164, 2000","journal-title":"Oncogene"},{"key":"5087780_CR10","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1128\/jvi.69.6.3420-3432.1995","volume":"69","author":"MJ Yin","year":"1995","unstructured":"Yin MJ, Paulssen EJ, Seeler JS, Gaynor RB: Protein domains involved in both in vivo and in vitro interactions between human T-cell leukemia virus type I tax and CREB. J Virol 69: 3420\u20133432, 1995","journal-title":"J Virol"},{"key":"5087780_CR11","doi-asserted-by":"crossref","first-page":"7270","DOI":"10.1128\/JVI.74.16.7270-7283.2000","volume":"74","author":"C de La Fuente","year":"2000","unstructured":"de La Fuente C, Santiago F, Chong SY, Deng L, Mayhood T, Fu P, Stein D, Denny T, Coffman F, Azimi N, Mahieux R, Kashanchi F: Overexpression of p21(waf1) in human T-cell lymphotropic virus type 1\u2013infected cells and its association with cyclin A\/cdk2. J Virol 74: 7270\u20137283, 2000","journal-title":"J Virol"},{"key":"5087780_CR12","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/0092-8674(95)90039-X","volume":"82","author":"C Deng","year":"1995","unstructured":"Deng C, Zhang P, Harper JW, Elledge SJ, Leder P: Mice lacking p21CIP1\/WAF1 undergo normal development, but are defective in G1 checkpoint control. Cell 82: 675\u2013684, 1995","journal-title":"Cell"},{"key":"5087780_CR13","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1021\/bi9903446","volume":"38","author":"X Xu","year":"1999","unstructured":"Xu X, Nakano T, Wick S, Dubay M, Brizuela L: Mechanism of Cyclin E\/cdk2 inhibition by p27 and p27 phosphorylation. Biochemistry 38: 8713\u20138722, 1999","journal-title":"Biochemistry"},{"key":"5087780_CR14","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/emboj\/16.2.332","volume":"16","author":"E Hara","year":"1997","unstructured":"Hara, E, Hall M, Peters G: Cdk2\u2013dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors. EMBO J 16: 332\u2013342, 1997","journal-title":"EMBO J"},{"key":"5087780_CR15","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1101\/gad.11.11.1479","volume":"11","author":"J Lukas","year":"1997","unstructured":"Lukas J, Herzinger T, Hansen K, Moroni MC, Resnitzky D, Helin K, Reed SI, Bartek J: Cyclin E-induced S phase without activation of the pRb\/E2F pathway. Genes Dev 11: 1479\u20131492, 1997","journal-title":"Genes Dev"},{"key":"5087780_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0960-9822(98)70021-1","volume":"8","author":"L Connell-Crowley","year":"1998","unstructured":"Connell-Crowley L, Elledge SJ, Harper JW: G1 cyclin-dependent kinases are sufficient to initiate DNA synthesis in quiescent human fibroblasts. Curr Biol 8: 65\u201368, 1998","journal-title":"Curr Biol"},{"key":"5087780_CR17","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1128\/MCB.18.8.4526","volume":"18","author":"W Seghezzi","year":"1998","unstructured":"Seghezzi W, Chua K, Shanahan F, Gozani O, Reed R, Lees E: Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells. Mol Cell Biol 18: 4526\u20134536, 1998","journal-title":"Mol Cell Biol"},{"key":"5087780_CR18","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1128\/MCB.19.2.1460","volume":"19","author":"F Shanahan","year":"1999","unstructured":"Shanahan F, Seghezzi W, Parry D, Mahony D, Lees E: Cyclin E associates with BAF155 and BRG1, components of the mammalian SWISNF complex, and alters the ability of BRG1 to induce growth arrest. Mol Cell Biol 19: 1460\u20131469, 1999","journal-title":"Mol Cell Biol"},{"key":"5087780_CR19","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1126\/science.275.5299.523","volume":"275","author":"ND Perkins","year":"1997","unstructured":"Perkins ND, Felzien LK, Betts JC, Leung K, Beach BH, Nabel GJ: Regulation of NF-kappaB by cyclin-dependent kinases associated with the p300 coactivator. Science 275: 523\u2013527, 1997","journal-title":"Science"},{"key":"5087780_CR20","doi-asserted-by":"crossref","first-page":"34646","DOI":"10.1074\/jbc.273.51.34646","volume":"273","author":"F Kashanchi","year":"1998","unstructured":"Kashanchi F, Duvall JF, Kwok, RP Lundblad JR, Goodman RH, Brady JN: The coactivator CBP stimulates human T-cell lymphotrophic virus type I Tax transactivation in vitro. J Biol Chem 273: 34646\u201334652, 1998","journal-title":"J Biol Chem"},{"key":"5087780_CR21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/930","volume":"19","author":"SF Anderson","year":"1998","unstructured":"Anderson SF, Schlegel BP, Nakajima T, Wolpin ES, Parvin JD: BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A. Nat Genet 19: 254\u2013256, 1998","journal-title":"Nat Genet"},{"key":"5087780_CR22","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S0092-8674(00)80376-1","volume":"90","author":"T Nakajima","year":"1997","unstructured":"Nakajima T, Uchida C, Anderson SF, Lee CG, Hurwitz J, Parvin JD, Montminy M: RNA helicase A mediates association of CBP with RNA polymerase II. Cell 90: 1107\u20131112, 1997","journal-title":"Cell"},{"key":"5087780_CR23","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1128\/MCB.19.6.4241","volume":"19","author":"LK Felzien","year":"1999","unstructured":"Felzien LK, Farrell S, Betts JC, Mosavin R, Nabel GJ: Specificity of cyclin E\/cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator. Mol Cell Biol 19: 4241\u20134246, 1999","journal-title":"Mol Cell Biol"},{"key":"5087780_CR24","first-page":"81","volume-title":"Transcriptional Regulation","author":"JL Corden","year":"1992","unstructured":"Corden JL, Ingles CJ: Carboxy-terminal domain of the large subunit of eukaryotic RNA polymerase II. In: SL McKnight and KR Yamamoto (eds). Transcriptional Regulation. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1992, pp 81\u2013109"},{"key":"5087780_CR25","doi-asserted-by":"crossref","first-page":"24563","DOI":"10.1074\/jbc.272.39.24563","volume":"272","author":"G Pan","year":"1997","unstructured":"Pan G, Aso T, Greenblatt J: Interaction of elongation factors TFIIS and elongin A with a human RNA polymerase II holoenzyme capable of promoter-specific initiation and responsive to transcriptional activators. J Biol Chem 272: 24563\u201324571, 1997","journal-title":"J Biol Chem"},{"key":"5087780_CR26","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1128\/MCB.19.9.6154","volume":"19","author":"K Yankulov","year":"1999","unstructured":"Yankulov K, Todorov I, Romanowski P, Licatalosi D, Cilli K, McCracken S, Laskey R, Bentley DL: MCM proteins are associated with RNA polymerase II holoenzyme. Mol Cell Biol 19: 6154\u20136163, 1999","journal-title":"Mol Cell Biol"},{"key":"5087780_CR27","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/emboj\/16.7.1638","volume":"16","author":"KY Yankulov","year":"1997","unstructured":"Yankulov KY, Bentley DL: Regulation of CDK7 substrate specificity by MAT1 and TFIIH. EMBO J 16: 1638\u20131646, 1997","journal-title":"EMBO J"},{"key":"5087780_CR28","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1128\/jvi.68.4.2726-2730.1994","volume":"68","author":"ST Butera","year":"1994","unstructured":"Butera ST, Roberts BD, Lam L, Hodge T, Folks TM: Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency. J Virol 68: 2726\u20132730, 1994","journal-title":"J Virol"},{"key":"5087780_CR29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/viro.1998.9578","volume":"255","author":"VA Morozov","year":"1999","unstructured":"Morozov VA, Weiss RA: Two types of HTLV-1 particles are released from MT-2 cells. Virology 255: 279\u2013284, 1999","journal-title":"Virology"},{"key":"5087780_CR30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1006\/viro.1993.1408","volume":"195","author":"LM Connor","year":"1993","unstructured":"Connor LM, Oxman MN, Brady JN, Marriott SJ: Twenty-one base pair repeat elements influence the ability of a Gal4\u2013Tax fusion protein to transactivate the HTLV-1 long terminal repeat. Virology 195: 569\u2013577, 1993","journal-title":"Virology"},{"key":"5087780_CR31","doi-asserted-by":"crossref","first-page":"6769","DOI":"10.1074\/jbc.273.12.6769","volume":"273","author":"S Trigon","year":"1998","unstructured":"Trigon S, Serizawa H, Conaway JW, Conaway RC, Jackson SP, Morange M: Characterization of the residues phosphorylated in vitro by different C-terminal domain kinases. J Biol Chem 273: 6769\u20136775, 1998","journal-title":"J Biol Chem"},{"key":"5087780_CR32","doi-asserted-by":"crossref","first-page":"24898","DOI":"10.1074\/jbc.273.38.24898","volume":"273","author":"M Benkirane","year":"1998","unstructured":"Benkirane M, Chun RF, Xiao H, Ogryzko VV, Howard BH, Nakatani Y, Jeang KT: Activation of integrated provirus requires histone acetyltransferase. p300 and P\/CAF are coactivators for HIV-1 Tat. J Biol Chem 273: 24898\u201324905, 1998","journal-title":"J Biol Chem"},{"key":"5087780_CR33","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1128\/MCB.18.7.4291","volume":"18","author":"MC Edwards","year":"1998","unstructured":"Edwards MC, Wong C, Elledge SJ: Human cyclin K, a novel RNA polymerase II-associated cyclin possessing both carboxy-terminal domain kinase and Cdk-activating kinase activity. Mol Cell Biol 18: 4291\u20134300, 1998","journal-title":"Mol Cell Biol"},{"key":"5087780_CR34","doi-asserted-by":"crossref","first-page":"8252","DOI":"10.1128\/JVI.72.10.8252-8256.1998","volume":"72","author":"MO Hottiger","year":"1998","unstructured":"Hottiger MO, Nabel GJ: Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J Virol 72: 8252\u20138256, 1998","journal-title":"J Virol"},{"key":"5087780_CR35","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1093\/emboj\/18.21.6106","volume":"18","author":"RE Kiernan","year":"1999","unstructured":"Kiernan RE, Vanhulle C, Schiltz L, Adam E, Xiao H, Maudoux F, Calomme C, Burny A, Nakatani Y, Jeang KT, Benkirane M, Van Lint C: HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J 18: 6106\u20136118, 1999","journal-title":"EMBO J"},{"key":"5087780_CR36","doi-asserted-by":"crossref","first-page":"13519","DOI":"10.1073\/pnas.95.23.13519","volume":"95","author":"G Marzio","year":"1998","unstructured":"Marzio G, Tyagi M, Gutierrez MI, Giacca M: HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc Natl Acad Sci USA 95: 13519\u201313524, 1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"5087780_CR37","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0960-9822(00)80120-7","volume":"9","author":"M Ott","year":"1999","unstructured":"Ott M, Schnolzer M, Garnica J, Fischle W, Emiliani S, Rackwitz HR, Verdin E: Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr Biol 9: 1489\u20131492, 1999","journal-title":"Curr Biol"},{"key":"5087780_CR38","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1038\/sj.onc.1202766","volume":"18","author":"T Suzuki","year":"1999","unstructured":"Suzuki T, Uchida-Toita M, Yoshida M: Tax protein of HTLV-1 inhibits CBP\/p300\u2013mediated transcription by interfering with recruitment of CBP\/p300 onto DNA element of E-box or p53 binding site. Oncogene 18: 4137\u20134143, 1999","journal-title":"Oncogene"},{"key":"5087780_CR39","first-page":"1645","volume":"12","author":"T Akagi","year":"1996","unstructured":"Akagi T, Ono H, Shimotohno K: Expression of cell-cycle regulatory genes in HTLV-1 infected T-cell lines: possible involvement of Tax1 in the altered expression of cyclin D2, p18Ink4 and p21Waf1\/Cip1\/ Sdi1. Oncogene 12: 1645\u20131652, 1996","journal-title":"Oncogene"},{"key":"5087780_CR40","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1006\/viro.1997.8489","volume":"231","author":"WA Bresnahan","year":"1997","unstructured":"Bresnahan WA, Boldogh I, Chi P, Thompson EA, Albrecht T: Inhibition of cellular Cdk2 activity blocks human cytomegalovirus replication. Virology 231: 239\u2013247, 1997","journal-title":"Virology"},{"key":"5087780_CR41","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1128\/JVI.72.7.5626-5637.1998","volume":"72","author":"LM Schang","year":"1998","unstructured":"Schang LM, Phillips J, Schaffer PA: Requirement for cellular cyclindependent kinases in herpes simplex virus replication and transcription. J Virol 72: 5626\u20135637, 1998","journal-title":"J Virol"},{"key":"5087780_CR42","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1128\/JVI.74.5.2107-2120.2000","volume":"74","author":"LM Schang","year":"2000","unstructured":"Schang LM, Rosenberg A, Schaffer PA: Roscovitine, a specific inhibitor of cellular cyclin-dependent kinases, inhibits herpes simplex virus DNA synthesis in the presence of viral early proteins. J Virol 74: 2107\u20132120, 2000","journal-title":"J Virol"},{"key":"5087780_CR43","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/JVI.73.3.2161-2172.1999","volume":"73","author":"LM Schang","year":"1999","unstructured":"Schang LM, Rosenberg A, Schaffer PA: Transcription of herpes simplex virus immediate-early and early genes is inhibited by roscovitine, an inhibitor specific for cellular cyclin-dependent kinases. J Virol 73: 2161\u20132172, 1999","journal-title":"J Virol"},{"key":"5087780_CR44","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.1128\/JVI.75.16.7266-7279.2001","volume":"75","author":"D Wang","year":"2001","unstructured":"Wang D, de la Fuente C, Deng L, Wang L, Zilberman I, Eadie C, Healey M, Harrison LE, Meijer L, Kashanchi F: Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors. J Virol 75: 7266\u20137279, 2001","journal-title":"J Virol"},{"key":"5087780_CR45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.281.5376.533","volume":"281","author":"NS Gray","year":"1998","unstructured":"Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, LeClerc S, Meijer L, Kim SH, Lockhart DJ, Schultz PG: Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281: 533\u2013538, 1998","journal-title":"Science"},{"key":"5087780_CR46","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/j.1432-1033.1997.t01-2-00527.x","volume":"243","author":"L Meijer","year":"1997","unstructured":"Meijer L, Borgne A, Mulner O, Chong JP, Blow JJ, Inagaki N, Inagaki M, Delcros JG, Moulinoux JP: Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. Eur J Biochem 243: 527\u2013536, 1997","journal-title":"Eur J Biochem"},{"key":"5087780_CR47","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0163-7258(98)00062-X","volume":"82","author":"EA Sausville","year":"1999","unstructured":"Sausville EA, Zaharevitz D, Gussio R, Meijer L, Louarn-Leost M, Kunick C, Schultz R, Lahusen T, Headlee D, Stinson S, Arbuck SG, Senderowicz A: Cyclin-dependent kinases: Initial approaches to exploit a novel therapeutic target. Pharmacol Ther 82: 285\u2013292, 1999","journal-title":"Pharmacol Ther"},{"key":"5087780_CR48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/sj.onc.1202399","volume":"18","author":"P Rickert","year":"1999","unstructured":"Rickert P, Corden JL, Lees E: Cyclin C\/CDK8 and cyclin H\/CDK7\/p36 are biochemically distinct CTD kinases. Oncogene 18: 1093\u20131102, 1999","journal-title":"Oncogene"},{"key":"5087780_CR49","doi-asserted-by":"crossref","first-page":"11920","DOI":"10.1073\/pnas.89.24.11920","volume":"89","author":"A Dvir","year":"1992","unstructured":"Dvir A, Peterson SR, Knuth MW, Lu H, Dynan WS: Ku autoantigen is the regulatory component of a template-associated protein kinase that phosphorylates RNA polymerase II. Proc Natl Acad Sci USA 89: 11920\u201311924, 1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"5087780_CR50","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0092-8674(93)90057-W","volume":"72","author":"T. M. Gottlieb","year":"1993","unstructured":"Gottlieb T M, Jackson SP: The DNA-dependent protein kinase: Requirement for DNA ends and association with Ku antigen. Cell 72: 131\u2013142, 1993","journal-title":"Cell"},{"key":"5087780_CR51","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1074\/jbc.270.3.1449","volume":"270","author":"SR Peterson","year":"1995","unstructured":"Peterson SR, Jesch SA, Chamberlin TN, Dvir A, Rabindran SK, Wu C, Dynan WS: Stimulation of the DNA-dependent protein kinase by RNA polymerase II transcriptional activator proteins. J Biol Chem 270: 1449\u20131454, 1995","journal-title":"J Biol Chem"},{"key":"5087780_CR52","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1073\/pnas.96.12.6626","volume":"96","author":"G Leone","year":"1999","unstructured":"Leone G, DeGregori J, Jakoi L, Cook JG, Nevins JR: Collaborative role of E2F transcriptional activity and G1 cyclin dependent kinase activity in the induction of S phase. Proc Natl Acad Sci USA 96: 6626\u20136631, 1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"5087780_CR53","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MCB.17.1.407","volume":"17","author":"K Zerfass-Thome","year":"1997","unstructured":"Zerfass-Thome K, Schulze A, Zwerschke W, Vogt B, Helin K, Bartek J, Henglein B, Jansen-Durr P: p27KIP1 blocks cyclin E-dependent transactivation of cyclin A gene expression. Mol Cell Biol 17: 407\u2013415, 1997","journal-title":"Mol Cell Biol"},{"key":"5087780_CR54","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/MCB.15.8.4215","volume":"15","author":"J DeGregori","year":"1995","unstructured":"DeGregori J, Kowalik T, Nevins JR: Cellular targets for activation by the E2F1 transcription factor include DNA synthesis-and G1\/S-regulatory genes. Mol Cell Biol 15: 4215\u20134224, 1995","journal-title":"Mol Cell Biol"},{"key":"5087780_CR55","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1038\/sj.onc.1202923","volume":"18","author":"L Delavaine","year":"1999","unstructured":"Delavaine L, La Thangue NB: Control of E2Factivity by p21 Waf1\/Cip1. Oncogene 18: 5381\u20135392, 1999","journal-title":"Oncogene"},{"key":"5087780_CR56","doi-asserted-by":"crossref","first-page":"13162","DOI":"10.1074\/jbc.274.19.13162","volume":"274","author":"DA Bochar","year":"1999","unstructured":"Bochar DA, Pan ZQ, Knights R, Fisher RP, Shilatifard A, Shiekhattar R: Inhibition of transcription by the trimeric cyclin-dependent kinase 7 complex. J Biol Chem 274: 13162\u201313166, 1999","journal-title":"J Biol Chem"},{"key":"5087780_CR57","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/viro.2000.0593","volume":"277","author":"L Deng","year":"2000","unstructured":"Deng L, de la Fuente C, Fu P, Wang L, Donnelly R, Wade J, Lambert P, Li H, Lee CG, Kashanchi F: Acetylation of HIV-1 Tat by CBP\/p300 increases transcription of Integrated HIV-1 genome, and enhances binding to core histones. Virology 277: 278\u2013295, 2000","journal-title":"Virology"},{"key":"5087780_CR58","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.1073\/pnas.86.15.5974","volume":"86","author":"EJ Duh","year":"1989","unstructured":"Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB: Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 86: 5974\u20135978, 1989","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016555821581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1016555821581\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1016555821581.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T13:50:06Z","timestamp":1747749006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1016555821581"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,8]]},"references-count":58,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["5087780"],"URL":"https:\/\/doi.org\/10.1023\/a:1016555821581","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,8]]}}}